JE
BCLI
JMAC Enterprises’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-65,430
| Closed | -$15.1K | – | 170 |
|
|
2024
Q3 | $15.1K | Hold |
65,430
| – | – | ﹤0.01% | 180 |
|
|
2024
Q2 | $22.1K | Hold |
65,430
| – | – | ﹤0.01% | 173 |
|
|
2024
Q1 | $36.9K | Hold |
65,430
| – | – | 0.01% | 167 |
|
|
2023
Q4 | $17.9K | Hold |
65,430
| – | – | ﹤0.01% | 169 |
|
|
2023
Q3 | $13.1K | Buy |
65,430
+25,000
| +62% | +$5K | ﹤0.01% | 160 |
|
|
2023
Q2 | $83.3K | Hold |
40,430
| – | – | 0.02% | 170 |
|
|
2023
Q1 | $133K | Hold |
40,430
| – | – | 0.03% | 174 |
|
|
2022
Q4 | $66.3K | Hold |
40,430
| – | – | 0.02% | 173 |
|
|
2022
Q3 | $179K | Sell |
40,430
-5,000
| -11% | -$22.1K | 0.05% | 169 |
|
|
2022
Q2 | $125K | Hold |
45,430
| – | – | 0.03% | 175 |
|
|
2022
Q1 | $153K | Hold |
45,430
| – | – | 0.04% | 175 |
|
|
2021
Q4 | $144K | Buy |
+45,430
| New | +$144K | 0.03% | 171 |
|